Ill health is taking a heavy toll on Europe's economies, with a new report estimating that sickness absence costs the European Union up to €810 billion annually. The figure, which includes both direct losses in productivity and wider economic ripple effects, underscores the urgent need for stronger prevention and earlier medical intervention.
The study, produced by the Environment and Public Health Institute and presented at the European Parliament in Brussels, calculates that the average European worker misses nearly three weeks of work each year due to illness. That accounts for roughly 6% of potential working time across the EU, translating into about €540 billion in lost labour costs — equivalent to 2.9% of the bloc's GDP in 2025.
However, that number only tells part of the story. The estimate covers sickness-related absence among people still classified as full-time employees. It does not capture the full economic impact of long-term ill health, such as when someone reduces their working hours or leaves the labour market entirely. Once those indirect costs are factored in — including lower output, the burden on employers and colleagues, reduced tax revenues, and higher social insurance spending — the total annual cost rises to between €675 billion and €810 billion.
Wide variation across member states
The report highlights a "dramatic difference across Europe" in how much sick leave people take, according to its author, Adrian Mehic. Data from the Organisation for Economic Co-operation and Development (OECD) shows that Slovenia had the longest average sick leave in 2025, with just over five weeks per employee. Finland and Spain follow closely, with around five weeks. France, Sweden and Germany all average slightly above three weeks, while Italy and Greece report less than one week per full-time employee.
Yet these figures do not necessarily reflect differences in population health, the report cautions. A country with fewer sick days might simply have a healthier workforce, but it could also indicate low compensation, weak employment protections, or a culture where people go to work despite being ill — a phenomenon known as presenteeism.
The economic consequences of absence are not limited to the individual. When someone is off sick, output declines, and employers must either hire temporary replacements or ask other staff to work overtime. Prolonged absences can push people out of the labour market altogether, shrinking the tax base and increasing public spending on benefits.
Prevention and early treatment as a solution
The report argues that a significant share of sick leave is avoidable. Many absences stem from conditions where preventive measures, early treatment, and rehabilitation can reduce both the likelihood and duration of absence. These include musculoskeletal problems, mental health issues, and chronic illnesses.
Mehic pointed to practical steps that could make a difference: better workplace ergonomics, earlier access to primary care and physiotherapy, prompt mental health support, and earlier detection of health risks. "A lot of these absences are preventable or can be shortened," he said during the presentation.
The findings come as European policymakers grapple with the economic fallout of an ageing population and rising healthcare costs. While the report does not propose specific policy changes, it adds to a growing body of evidence that investing in prevention and early intervention can yield substantial economic returns.
For businesses, the message is clear: supporting employee health is not just a moral imperative but an economic one. For governments, the report reinforces the case for robust public health systems and workplace regulations that encourage early treatment rather than prolonged absence.
As Europe continues to navigate post-pandemic recovery and the pressures of an ageing workforce, the cost of sick leave is likely to remain a key concern for both national treasuries and employers across the continent.


